SK148199A3 - Cox-2 selective carprofen for treating pain and inflammation in dogs - Google Patents
Cox-2 selective carprofen for treating pain and inflammation in dogs Download PDFInfo
- Publication number
- SK148199A3 SK148199A3 SK1481-99A SK148199A SK148199A3 SK 148199 A3 SK148199 A3 SK 148199A3 SK 148199 A SK148199 A SK 148199A SK 148199 A3 SK148199 A3 SK 148199A3
- Authority
- SK
- Slovakia
- Prior art keywords
- cox
- carprofen
- group
- inflammatory
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4563597P | 1997-05-05 | 1997-05-05 | |
| PCT/IB1998/000662 WO1998050033A1 (fr) | 1997-05-05 | 1998-05-01 | Carprofene inhibant selectivement cox-2 et utilise dans le traitement de la douleur et des inflammations chez les chiens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK148199A3 true SK148199A3 (en) | 2001-09-11 |
Family
ID=21939053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1481-99A SK148199A3 (en) | 1997-05-05 | 1998-05-01 | Cox-2 selective carprofen for treating pain and inflammation in dogs |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP0988034A1 (fr) |
| JP (1) | JP2000513020A (fr) |
| KR (2) | KR20040004406A (fr) |
| CN (1) | CN1255059A (fr) |
| AP (1) | AP9801234A0 (fr) |
| AR (2) | AR011726A1 (fr) |
| AU (1) | AU6932198A (fr) |
| BG (1) | BG103852A (fr) |
| BR (1) | BR9808720A (fr) |
| CA (1) | CA2288759A1 (fr) |
| DZ (1) | DZ2479A1 (fr) |
| EA (1) | EA003696B1 (fr) |
| GT (1) | GT199800063A (fr) |
| HR (1) | HRP980244A2 (fr) |
| HU (1) | HUP0001286A3 (fr) |
| ID (1) | ID21311A (fr) |
| IL (1) | IL132570A0 (fr) |
| IS (1) | IS5220A (fr) |
| MA (1) | MA26491A1 (fr) |
| NO (1) | NO995389L (fr) |
| NZ (1) | NZ500183A (fr) |
| OA (1) | OA11213A (fr) |
| PA (1) | PA8450601A1 (fr) |
| PE (1) | PE72599A1 (fr) |
| PL (1) | PL337003A1 (fr) |
| SK (1) | SK148199A3 (fr) |
| TN (1) | TNSN98059A1 (fr) |
| TW (1) | TW590773B (fr) |
| UY (1) | UY24989A1 (fr) |
| WO (1) | WO1998050033A1 (fr) |
| YU (1) | YU55899A (fr) |
| ZA (1) | ZA983722B (fr) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6245797B1 (en) | 1997-10-22 | 2001-06-12 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease |
| AU2003204888B2 (en) * | 1998-05-22 | 2005-07-28 | Pfizer Products Inc. | Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives |
| US6506785B2 (en) | 1998-05-22 | 2003-01-14 | Pfizer, Inc. | Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives |
| AU764872B2 (en) * | 1998-10-23 | 2003-09-04 | Merck Frosst Canada & Co. | Combination product comprising an E-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| WO2000053149A2 (fr) * | 1999-03-10 | 2000-09-14 | G.D. Searle & Co. | Procede et composition se rapportant a l'administration d'un inhibiteur de la cyclo-oxygenase-2 |
| WO2001034204A1 (fr) * | 1999-11-11 | 2001-05-17 | Eli Lilly And Company | Produits composes oncolytiques destines au traitement du cancer |
| JP2004521856A (ja) * | 2000-05-15 | 2004-07-22 | メルク フロスト カナダ アンド カンパニー | Ｃｏｘ−２選択的阻害剤およびトロンボキサン阻害剤を用いる併用療法ならびにそのための組成物 |
| RU2003100874A (ru) | 2000-06-13 | 2004-06-27 | Вайс (Us) | Болеутоляющие и противовоспалительные составы, содержащие ингибиторы циклооксигеназы-2 |
| DE10032132A1 (de) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung |
| US7189504B2 (en) | 2000-08-07 | 2007-03-13 | Vanderbilt University | Compositions and methods for detecting and quantifying COX-2 activity and 2-arachidonylglycerol metabolites |
| US20040209959A1 (en) * | 2001-07-16 | 2004-10-21 | Edward Hogestatt | Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation |
| CA2519189C (fr) | 2003-05-07 | 2012-07-17 | Osteologix A/S | Sels de strontium solubles dans l'eau pour le traitement de maladies des cartilages et/ou des os |
| KR100780983B1 (ko) * | 2003-07-31 | 2007-11-30 | 파마시아 앤드 업존 캄파니 엘엘씨 | 소염제의 분산성 제제 |
| WO2006123247A2 (fr) * | 2005-05-20 | 2006-11-23 | Pfizer Limited | Combinaisons synergiques |
| WO2008122967A2 (fr) | 2007-04-04 | 2008-10-16 | Sigmoid Pharma Limited | Composition pharmaceutique orale |
| WO2008132707A1 (fr) | 2007-04-26 | 2008-11-06 | Sigmoid Pharma Limited | Fabrication de minicapsules multiples |
| US9278070B2 (en) | 2009-05-18 | 2016-03-08 | Sigmoid Pharma Limited | Composition comprising oil drops |
| EP2464341B1 (fr) | 2009-08-12 | 2022-07-06 | Sublimity Therapeutics Limited | Compositions immunomodulatrices comprenant une matrice polymère et une phase huileuse |
| GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
| GB201212010D0 (en) | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
| GB201319791D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
| DK3113774T3 (da) | 2014-03-06 | 2022-03-07 | Elanco Animal Health Incorporated | Sammensætninger af grapiprant og fremgangsmåder til anvendelse deraf |
| EA036036B1 (ru) | 2014-11-07 | 2020-09-16 | Сигмойд Фарма Лимитед | Композиции, содержащие циклоспорин |
| US12109218B2 (en) | 2014-12-09 | 2024-10-08 | Aratana Therapeutics, Inc. | Compositions of grapiprant and methods for using the same |
| MX2017009011A (es) * | 2015-01-09 | 2017-10-02 | Jaguar Animal Health | Metodos para tratar la diarrea en animales de compañia. |
| JP2023520367A (ja) * | 2020-03-25 | 2023-05-17 | エスアールアイ インターナショナル | リポキシゲナーゼ阻害剤 |
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
| KR102404883B1 (ko) | 2020-11-30 | 2022-06-07 | (주)이노보테라퓨틱스 | 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3896145A (en) * | 1972-07-24 | 1975-07-22 | Hoffmann La Roche | Carbazoles |
| CA1319886C (fr) * | 1987-02-03 | 1993-07-06 | Alberto Ferro | Solutions de micelles mixtes |
-
1998
- 1998-03-02 DZ DZ980089A patent/DZ2479A1/fr active
- 1998-04-30 TW TW087106689A patent/TW590773B/zh not_active IP Right Cessation
- 1998-05-01 AU AU69321/98A patent/AU6932198A/en not_active Abandoned
- 1998-05-01 EA EA199900895A patent/EA003696B1/ru not_active IP Right Cessation
- 1998-05-01 YU YU55899A patent/YU55899A/sh unknown
- 1998-05-01 ID IDP980651A patent/ID21311A/id unknown
- 1998-05-01 SK SK1481-99A patent/SK148199A3/sk unknown
- 1998-05-01 HU HU0001286A patent/HUP0001286A3/hu unknown
- 1998-05-01 JP JP10547869A patent/JP2000513020A/ja active Pending
- 1998-05-01 CN CN98804845A patent/CN1255059A/zh active Pending
- 1998-05-01 NZ NZ500183A patent/NZ500183A/en unknown
- 1998-05-01 EP EP98915041A patent/EP0988034A1/fr not_active Withdrawn
- 1998-05-01 IL IL13257098A patent/IL132570A0/xx unknown
- 1998-05-01 BR BR9808720-7A patent/BR9808720A/pt not_active IP Right Cessation
- 1998-05-01 CA CA002288759A patent/CA2288759A1/fr not_active Abandoned
- 1998-05-01 WO PCT/IB1998/000662 patent/WO1998050033A1/fr not_active Application Discontinuation
- 1998-05-01 KR KR10-2003-7005258A patent/KR20040004406A/ko not_active Application Discontinuation
- 1998-05-01 KR KR1019997010252A patent/KR20010012300A/ko not_active Application Discontinuation
- 1998-05-01 PL PL98337003A patent/PL337003A1/xx unknown
- 1998-05-04 MA MA25059A patent/MA26491A1/fr unknown
- 1998-05-04 PE PE1998000335A patent/PE72599A1/es not_active Application Discontinuation
- 1998-05-04 TN TNTNSN98059A patent/TNSN98059A1/fr unknown
- 1998-05-04 UY UY24989A patent/UY24989A1/es not_active Application Discontinuation
- 1998-05-04 ZA ZA9803722A patent/ZA983722B/xx unknown
- 1998-05-04 GT GT199800063A patent/GT199800063A/es unknown
- 1998-05-04 AP APAP/P/1998/001234A patent/AP9801234A0/en unknown
- 1998-05-05 AR ARP980102089A patent/AR011726A1/es unknown
- 1998-05-05 HR HR60/045,635A patent/HRP980244A2/hr not_active Application Discontinuation
- 1998-05-05 PA PA19988450601A patent/PA8450601A1/es unknown
-
1999
- 1999-10-19 IS IS5220A patent/IS5220A/is unknown
- 1999-11-02 OA OA9900242A patent/OA11213A/en unknown
- 1999-11-03 BG BG103852A patent/BG103852A/xx unknown
- 1999-11-04 NO NO995389A patent/NO995389L/no not_active Application Discontinuation
-
2003
- 2003-04-09 AR ARP030101251A patent/AR039628A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK148199A3 (en) | Cox-2 selective carprofen for treating pain and inflammation in dogs | |
| EP1032424B1 (fr) | Combinaison d'un inhibiteur de reductase d'aldose et d'un inhibiteur de phosphorylase de glycogene | |
| EP1126841B1 (fr) | Combinaisons d'une agoniste 5ht1b/1d et d'un inhibiteur selective de cox-2 destinees au traitement de migraine | |
| CA2525772C (fr) | Methode de traitement de l'atherosclerose, dyslipidemie et etats relatifs et compositions pharmaceutiques | |
| US20210047268A1 (en) | Methods for inhibiting native and promiscuous uptake of monoamine neurotransmistters | |
| TW201002311A (en) | Novel compositions and methods for treating hyperproliferative diseases | |
| Revermann et al. | A pirinixic acid derivative (LP105) inhibits murine 5‐lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysm | |
| US20030212123A1 (en) | COX-2 selective carprofen for treating pain and inflammation in dogs | |
| CZ15698A3 (cs) | Použití nesteroidního protizánětlivého prostředku pro výrobu farmaceutického prostředku | |
| US20040156892A1 (en) | Soft shell gelatin capsules containing non-steroidal anti-inflammatories | |
| AU773615B2 (en) | COX-2 selective carprofen for treating pain and inflammation in dogs | |
| JP2000086629A (ja) | 新規な酸化窒素放出化合物 | |
| JP5579958B2 (ja) | Ｃｏｘ−２インヒビターを含有する鎮痛及び抗炎症性組成物 | |
| CZ9903896A3 (cs) | Léčivo, farmaceutický přípravek a souprava pro léčení nebo prevenci bolesti a zánětlivých procesů | |
| NZ516914A (en) | Compositions containing COX-2 selective carprofen and derivatives thereof for treating pain and inflammation in dogs | |
| US20160346249A1 (en) | Use of amitifadine, (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in methods and compositions with enhanced efficacy and reduced metabolic side effects and toxicity for treatment of depression and other central nervous system disorders and conditions affected by monoamine neurotransmitters | |
| US20110034531A1 (en) | Use of hdac inhibitors for the treatment of melanoma | |
| NZ515513A (en) | Method for treating chronic obstructive pulmonary disease using an endothelin A receptor antagonist | |
| MXPA99008048A (en) | Oxynolic developers oxidonitric releases for analgesic, anti-inflammatory use and as a sick modifier | |
| WO2008002634A1 (fr) | Utilisation d'inhibiteurs de la hdac pour le traitement des lymphomes |